Canadian scientist wins Breakthrough Prize for discovery of hormone used in Ozempic, Mounjaro
The Breakthrough Discovery of GLP-1 Hormone: A Revolution in Medicine Canadian researcher Dr. Daniel Drucker’s discovery of the GLP-1 hormone—transformative in treating diabetes and obesity—has catalyzed a medical revolution. Medications such as Ozempic, Wegovy, and Mounjaro have already impacted millions globally, offering new hope to those battling these conditions. Current Successes in Diabetes and Obesity … Read more